Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 3/20 | 0.36 |
| ▸ | TK1 | P04183 | 3/20 | 0.35 |
| ▸ | TK2 | O00142 | 1/20 | 0.35 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | TYMP | P19971 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24217787 | 0.94 | RNASE1 (0.39) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL20706336 | 0.94 | RNASE1 (0.39) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL20706307 | 0.91 | RNASE1 (0.37) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL24217750 | 0.91 | RNASE1 (0.37) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL20706330 | 0.90 | RNASE1 (0.39) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL9550769 | 0.90 | RNASE1 (0.40) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL22984007 | 0.90 | RNASE1 (0.40) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL13930549 | 0.90 | RNASE1 (0.40) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL13901245 | 0.90 | RNASE1 (0.40) | RNASE1TOP2ATK1TK2TYMS | |
| SCHEMBL2031822 | 0.90 | RNASE1 (0.40) | RNASE1TOP2ATK1TK2TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6160152-A | Process for the synthesis of oligomeric compounds | ISIS PHARMACEUTICALS, INC. (US) | 2000-12-12 | — | — | US | disclosed |
| US-6020475-A | Process for the synthesis of oligomeric compounds | ISIS PHARMEUTICALS, INC. (US) | 2000-02-01 | — | — | US | disclosed |